Drugs / BCG
last change Apr 2025 re-read 2 minutes ago

BCG

Developed for
bladder carcinoma in situ
Investigated by
Mayo Clinic · National Center for Advancing Translational Sciences (NCATS)

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT06704191 Apr 2025 → Dec 2026 expected bladder carcinoma in situ Mayo Clinic Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT06704191